FAP-IL12

N/A

Report date: 2022/05/10 11:40:04

Base Information

Drug NameFAP-IL12
Drug Alias NameFAPIL12
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFibroblast activation protein alpha antagonistsInterleukin-2 replacements
TargetsInterleukin-2Prolyl endopeptidase FAP
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhilogen Spa
China Registration ClassN/A

Develop Information

Active CompaniesPhilogen Spa
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A